Mirae Asset Global Investments’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-21,570
Closed -$381K – 2465
2023
Q4
$381K Hold
21,570
– – ﹤0.01% 2096
2023
Q3
$518K Hold
21,570
– – ﹤0.01% 1864
2023
Q2
$502K Buy
+21,570
New +$488K ﹤0.01% 1949
2015
Q1
– Sell
-9,338
Closed -$1.12M – 476
2014
Q4
$1.12M Sell
9,338
-228
-2% -$29.9K 0.04% 252
2014
Q3
$1.4M Buy
9,566
+971
+11% +$150K 0.05% 210
2014
Q2
$1.44M Buy
8,595
+1,139
+15% +$203K 0.03% 207
2014
Q1
$1.48M Sell
7,456
-443
-6% -$83.6K 0.04% 194
2013
Q4
$1.51M Buy
7,899
+115
+1% +$21.4K 0.06% 210
2013
Q3
$1.32M Buy
+7,784
New +$1.21M 0.06% 207

Other funds holding CLB

Mirae Asset Global Investments's CLB Position: Q1 2024 in Review

Mirae Asset Global Investments sold out of Core Laboratories (CLB) in Q1 2024, closing a stake of 21,570 shares — an estimated $381K sold.

Mirae Asset Global Investments first reported a position in CLB in Q3 2013 and held it in 9 quarters. The position peaked at $1.51M in Q4 2013. 197 funds tracked by Wall St. Rank hold CLB as of Q1 2024.

  • Mirae Asset Global Investments reported no remaining Core Laboratories position as of Q1 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 21,570 Core Laboratories shares in Q1 2024, an estimated $381K.
  • Mirae Asset Global Investments first reported a position in Core Laboratories in Q3 2013 and held it in 9 quarters.
  • Mirae Asset Global Investments's Core Laboratories position peaked at $1.51M in Q4 2013.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2024.

Based on Mirae Asset Global Investments's 13F filing for Q1 2024, filed 1 May 2024.